Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{171350,
        author = {Tanaya Patyane and Nikita Pagare and Dr. Manisha Nangude and Yogita Patil and Om Patil},
        title = {An overview on Transdermal patch},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {7},
        pages = {3332-3340},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=171350},
        abstract = {Transdermal drug delivery systems (TDDS) provide a regulated release of medication directly into the bloodstream, ensuring stable drug concentrations and potentially minimizing systemic side effects while improving efficacy compared to other methods of administration. This non-invasive technique offers a painless and convenient option for patients. The skin is a favorable route for drug delivery due to its large surface area, easy accessibility, and connection to both the circulatory and lymphatic systems, which enable systemic absorption. The primary objective of TDDS is to deliver medication at a consistent rate, reducing both interpatient and intrapatient variability. These systems are increasingly recognized for offering significant therapeutic benefits to patients worldwide.},
        keywords = {Transdermal patches, Controlled release, vapour patches, in vitro permeation study},
        month = {December},
        }